Navigation Links
Innovations in Pediatric Medicine CME conference brings together national pediatrics experts
Date:10/14/2008

NEW YORK (Oct. 14, 2008) -- In the last decade, biomedical and research breakthroughs, notably in genetics and stem cells, have helped transform the care of children, improving diagnosis and treatment for numerous diseases. On Nov. 8 and 9, Morgan Stanley Children's Hospital of NewYork-Presbyterian and Columbia University Medical Center will host a conference at the Grand Hyatt New York, titled "Innovations in Pediatric Medicine," to exchange the latest advances in genetics, stem cell therapy, and childhood disease treatment.

The continuing medical education (CME) conference will feature lectures by international leading authorities in pediatric care in congenital and primary immunodeficiencies, gene therapy in children, the genetic basis for common childhood infections and a rational approach to pediatric emergency care during unplanned national or regional disasters.

"Medical breakthroughs have greatly increased the range of treatment options for pediatric diseases, which is why we are thrilled to bring together medical professionals who are on the frontline of pediatric care for this opportunity of learning the latest progress and the sharing of best practices," says the conference's course director, Dr. Mitchell Cairo, director of pediatric blood and marrow transplantation at Morgan Stanley Children's Hospital of NewYork-Presbyterian and professor of pediatrics, medicine and pathology at Columbia University College of Physicians and Surgeons.

A brief listing of speakers and topics is below. For the complete two-day conference program, visit: www.nyp.org/pdf/innovations_cme_schedule.pdf.

Saturday, Nov. 8
Plenary I

Bench to Bedside Genetics: A Pediatrician's Viewpoint

Moderator:
Dr. Gerald M. Loughlin, Phyllis and David Komansky Center for Children's Health at NewYork-Presbyterian Hospital/Weill Cornell Medical Center and Wei
'/>"/>

Contact: Belinda Mager
bem9048@nyp.org
212-305-5587
New York- Presbyterian Hospital/Columbia University Medical Center
Source:Eurekalert

Page: 1 2 3 4

Related biology news :

1. OHSU turns innovations into commercial opportunities at record pace
2. Synaptics SecurePad(TM) Selected as CES Innovations 2008 Design and Engineering Award Honoree
3. Sonic Innovations Celebrates 10-Year Anniversary
4. New chemical radar among national security innovations in ACS podcast
5. Improving industry efficiency through environmental innovations
6. Leading pediatrician addresses the future of childrens health
7. Pediatricians alerted to the developmental nature of underage drinking in special journal supplement
8. Immunotherapy in high-risk pediatric sarcomas shows promising response
9. Immune system protein accurate predictor of survival in pediatric septic shock
10. New research seeks to enhance quality and security of wireless telemedicine
11. Penn Veterinary Medicine report new strategy to create genetically-modified animals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/8/2015)... YORK , July 8, 2015 Summary ... globally, and the fourth most fatal, with a mortality ... The poor prognosis of pancreatic cancer patients has highlighted ... treatment, which is not being met by the current ... an array of products with varying molecule types and ...
(Date:7/8/2015)... -- The consumer products industry for innovative tech ... such as wearables, smart wallets & other smart technology are ... continues to rapidly grow.  Biometrics & Wearable Device Companies in ... Inc. (NASDAQ: GOOG ), Apple Inc. (NASDAQ: AAPL ... GPRO ) and Baidu Inc. (NASDAQ: BIDU ) ...
(Date:7/7/2015)... Conn. , July 7, 2015 NXT-ID, Inc. (NASDAQ: ... focused on the growing mobile commerce market announces a revised version ... this week. The commercial will air on CNBC in ... Los Angeles and San Francisco ... The commercial focuses on Wocket,s ability to replace all the cards ...
Breaking Biology News(10 mins):Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 2Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 3Consumers Flock to This Summer's Must Have Tech Gadgets as Latest Digital Wallets, Smart Technology & Wearable Products Continue to Grow in Popularity & Functionality 2Consumers Flock to This Summer's Must Have Tech Gadgets as Latest Digital Wallets, Smart Technology & Wearable Products Continue to Grow in Popularity & Functionality 3Consumers Flock to This Summer's Must Have Tech Gadgets as Latest Digital Wallets, Smart Technology & Wearable Products Continue to Grow in Popularity & Functionality 4Consumers Flock to This Summer's Must Have Tech Gadgets as Latest Digital Wallets, Smart Technology & Wearable Products Continue to Grow in Popularity & Functionality 5Consumers Flock to This Summer's Must Have Tech Gadgets as Latest Digital Wallets, Smart Technology & Wearable Products Continue to Grow in Popularity & Functionality 6Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 2Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 3
... Osteoporosis Foundation (IOF) is pleased to announce the inaugural ... best pre-clinical and translational science in bone biology to ... European Congress on Osteoporosis and Osteoarthritis (ECCEO11-IOF) in Valencia ... Karsenty, Professor and Chair, Genetics & Development, Columbia University ...
... likely to alter plant diseases of the future. Researchers ... the preindustrial era by the year 2050, complicating agriculture,s ... population. University of Illinois researchers are studying ... higher atmospheric temperatures on plant diseases that could challenge ...
... University of Leicester will use the latest genetic techniques ... disease. The study will help to identify new ... This, in turn may help to develop new diagnostic ... by postgraduate researcher Paraskevi Christofidou, of the Department of ...
Cached Biology News:Climate change complicates plant diseases of the future 2Climate change complicates plant diseases of the future 3How genetic 'chips' could help to understand heart disease 2
(Date:7/28/2015)... July 21, 2015 ... the addition of the "Analysis of the ... their offering. Globally, flow cytometry remains ... cell proliferation, cancer, and stem cells. But the ... primarily because of demand from underdeveloped nations to ...
(Date:7/28/2015)... 21, 2015 Research and Markets ( ... "Biomedical Refrigerators and Freezers Market - Global ... 2014 - 2022" report to their offering. ... freezers market has been segmented based on applications: ... and others. The others segment includes applications of ...
(Date:7/28/2015)... , ... July 28, 2015 , ... VetStem Biopharma will ... stem cell credentialing course to local area veterinarians. , The tour and course will ... units at no charge) at VetStem’s Poway facility. Staff members are welcome to attend ...
(Date:7/28/2015)... YORK , July 28, 2015 Deerfield ... Deerfield Healthcare Innovations Fund, L.P., which will invest in ... interventions in genetic diseases, cancer, and orphan diseases. The ... can transform how therapeutics are developed and improve the ... fund, one of the largest healthcare-focused venture funds in ...
Breaking Biology Technology:Analysis of the Global Flow Cytometry Market 2012-2018 with a 2014 Base Year and a 2015-2018 Forecast Period 2Biomedical Refrigerators and Freezers Market Report - Global Industry Analysis 2015 2Biomedical Refrigerators and Freezers Market Report - Global Industry Analysis 2015 3VetStem Biopharma weekly veterinary continuing education classes and GMP manufacturing facility tour 2Deerfield Launches $550 Million Healthcare Venture-Capital Fund 2Deerfield Launches $550 Million Healthcare Venture-Capital Fund 3
... chooses AMICAS to drive improvements in customer ... service and operational efficiency, ... leader in radiology and medical image and information management,solutions, today ... California,s most influential radiology groups., (Logo: http://www.newscom.com/cgi-bin/prnh/20060202/AMICASLOGO ...
... July 28 Ranbaxy,Pharmaceuticals Inc. (RPI), a ... Gurgaon, India announced today that under an,agreement ... authorized,generic of Omeprazole 40 mg Capsules in ... indicated for the treatment of acid-related disease,including ...
... Pa., July 25 BioTrends Research Group, Inc.,released ... offering comprehensive insight into the management of,renal anemia ... Disease,(CKD) and Dialysis. The report provides information from ... online survey fielded in,June 2008., In the ...
Cached Biology Technology:Arcadia Radiology Medical Group Chooses AMICAS 2Arcadia Radiology Medical Group Chooses AMICAS 3Ranbaxy Launches Omeprazole 40 mg Capsules 2BioTrends Releases Quarterly TreatmentTrends(TM): Nephrology Report Highlighting Market Trends for Renal Anemia, Hyperphosphatemia, and Secondary Hyperparathyroidism 2BioTrends Releases Quarterly TreatmentTrends(TM): Nephrology Report Highlighting Market Trends for Renal Anemia, Hyperphosphatemia, and Secondary Hyperparathyroidism 3
... power of your ValveBank system! Program your ... computer running Windows 98, 2000, XP using graphic ... disk, print out program listings, then download your ... step., EasyCode is used for programming before -- ...
... DNA Ligase catalyzes the formation of phosphodiester ... double-stranded DNAs with 3' hydroxyl and 5' ... buffer optimizes ligation which can be performed ... are not substrates for this enzyme. ...
... is a major step forward in ... handling system - with one universal ... modules. All five single channel and ... one handle. The lightweight handle is ...
alpha-N-Catenin Antibody Shipping Temperature: HOT Storage Temperature: -20C...
Biology Products: